PT  - JOURNAL ARTICLE
AU  - Soulmaz Fazeli Farsani
AU  - Patrick C Souverein
AU  - Marja M J van der Vorst
AU  - Catherijne A J Knibbe
AU  - Anthonius de Boer
AU  - Aukje K Mantel-Teeuwisse
TI  - Chronic comorbidities in children with type 1 diabetes: a population-based cohort study
AID  - 10.1136/archdischild-2014-307654
DP  - 2015 Aug 01
TA  - Archives of Disease in Childhood
PG  - 763--768
VI  - 100
IP  - 8
4099  - http://adc.bmj.com/content/100/8/763.short
4100  - http://adc.bmj.com/content/100/8/763.full
SO  - Arch Dis Child2015 Aug 01; 100
AB  - Objective To determine the incidence of chronic comorbidities among children with type 1 diabetes (T1D) and to compare incidences with a group of children without diabetes.Design Population-based cohort study.Setting Dutch PHARMO database (1998–2010).Patients All patients (<19 years old) with T1D between 1999 and 2009 (T1D cohort) and a group of age- and sex-matched (ratio: 1–4) children without diabetes (reference cohort).Main outcome measure The incidence of nine common chronic comorbidities was assessed on the basis that they were treated pharmacologically and/or resulted in hospital admission. Cox proportional hazard analysis was used to estimate the strength of the association between T1D and comorbidities, expressed as HRs and 95% CIs.Results A total of 915 patients with T1D and 3590 children in the reference cohort (51% boys, mean age of 10.1 (SD 4.5) years) were included. T1D was associated with an increased risk (HR; 95% CI) of hospitalisation for any comorbidity (3.7; 2.5 to 5.5), thyroid disease (14.2; 6.7 to 31.0), non-infectious enteritis and colitis (5.9; 3.0 to 11.5), cardiovascular disorders (3.1; 2.3 to 4.2), mental disorders (2.0; 1.4 to 3.1), epilepsy (2.0; 1.1 to 3.7) and (obstructive) pulmonary disease (1.5; 1.2 to 2.0). There was no significant difference in the incidences of other comorbidities (malignant disorders, anaemia and migraine) between the two cohorts.Conclusions Our longitudinal study showed that incidences of six chronic diseases were significantly higher in T1D children during the early years of developing this disease compared with the reference children.